American Well Corporation (AMWL) reported a Q2 loss of $1.24 per share, significantly outperforming the Zacks Consensus Estimate of a $1.84 loss and marking a substantial improvement from a $3.36 loss a year prior. The company also posted revenues of $70.9 million, surpassing consensus estimates by 11.42% and increasing from $62.79 million year-over-year. Despite these beats, AMWL shares have underperformed the S&P 500 year-to-date, and the stock's immediate price movement will largely hinge on management's commentary during the upcoming earnings call, with the stock currently holding a Zacks Rank #3 (Hold).
American Well Corporation (AMWL) delivered a notably strong second quarter, outperforming analyst expectations on both revenue and earnings. The company reported a loss of $1.24 per share, which was a significant 32.61% positive surprise compared to the Zacks Consensus Estimate of a $1.84 loss. This also represents a substantial improvement from the $3.36 loss per share recorded in the same quarter a year ago. On the top line, revenues reached $70.9 million, surpassing consensus estimates by 11.42% and growing from $62.79 million year-over-year. This marks the fourth consecutive quarter of beating EPS estimates, establishing a pattern of outperformance. However, this positive operational report is contrasted by the stock's material underperformance year-to-date, having lost 2.9% while the S&P 500 gained 7.6%. The pivotal question remains the forward outlook, as current consensus for the upcoming quarter projects a sequential decline in revenue to $63.11 million and a wider loss. The stock's Zacks Rank #3 (Hold) reflects this uncertainty, indicating that while the company operates in a favorable industry (top 29%), the market is awaiting clarity from management's upcoming earnings call to determine the sustainability of this momentum.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
moderately positive
Sentiment Score
0.55
Ticker Sentiment